LBA3 Transarterial chemoembolization (TACE) with or without lenvatinib (len) + pembrolizumab (pembro) for intermediate-stage hepatocellular carcinoma (HCC): Phase III LEAP-012 study
J. Llovet,R.S. Finn,Z. Ren,Yiying Guo,Guiyan Han,Haiyan Lin,Jie Zheng,Sadahisa Ogasawara,H. Li,Jeong Ho Kim,Huanyu Zhao,C. Li,David C. Madoff,R. Mark Ghobrial,Anthony B. El-Khoueiry,Arndt Vogel,Xiao‐Xia Peng,K. Mody,L. Dubrovsky,M. Kudo